Back to
Miss Georgia McCaughan
Senior Research Associate

Miss Georgia McCaughan

BMedSc MBBS (University Medal) MMed (Clin Epi) FRACP FRCPA

Medicine & Health
School of Clinical Medicine

Specialties
 Clinical and Laboratory Haematology

Department
Haematology

Areas of Interest
Plasma cell disorders including multiple myeloma and AL amyloidosis

Roles
Staff Specialist Haematologist, St Vincent’s Public Hospital


VMO Haematologist, St Vincent’s Private Hospital


Senior Research Associate, University of New South Wales
 
Phone
02 9355 5656
Location
The Kinghorn Cancer Centre, 370 Victoria Street, Darlinghurst. NSW 2010
  • Journal articles | 2023
    2023, 'Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care', JNCCN Journal of the National Comprehensive Cancer Network, 21, pp. 366 - 372, http://dx.doi.org/10.6004/jnccn.2022.7255
    Journal articles | 2022
    2022, 'Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort', Internal Medicine Journal, 52, pp. 69 - 78, http://dx.doi.org/10.1111/imj.15072
    Journal articles | 2022
    2022, 'Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review', British Journal of Haematology, 199, pp. 190 - 204, http://dx.doi.org/10.1111/bjh.18295
    Journal articles | 2022
    2022, 'OAB-048: An interim analysis of a phase I/II single arm study of belantamab mafodotin, carfilzomib and dexamethasone in patients with relapsed multiple myeloma: AMaRC 19-02 BelaCarD study', Clinical Lymphoma Myeloma and Leukemia, 22, pp. S29 - S30, http://dx.doi.org/10.1016/s2152-2650(22)00321-4
    Journal articles | 2022
    2022, 'P1573: VARIATION IN USE OF IMMUNOGLOBULIN AND IMPACT ON SURVIVAL IN MULTIPLE MYELOMA: A REPORT FROM THE AUSTRALIA/NEW ZEALAND (ANZ) AND ASIA-PACIFIC (APAC) MYELOMA AND RELATED DISEASES REGISTRIES (MRDR)', HemaSphere, 6, pp. 1454 - 1455, http://dx.doi.org/10.1097/01.hs9.0000849148.93868.54
    Journal articles | 2022
    2022, 'P946: A PHASE I/II SINGLE ARM STUDY OF BELANTAMAB MAFODOTIN, CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA: AMARC 19-02 BELACARD STUDY.', HemaSphere, 6, pp. 836 - 837, http://dx.doi.org/10.1097/01.hs9.0000846652.51254.ac
    Journal articles | 2022
    2022, 'Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant', Blood Advances, 6, pp. 4949 - 4966, http://dx.doi.org/10.1182/bloodadvances.2022007103
    Journal articles | 2021
    2021, 'A Minority of Women of Child Bearing Potential Are Tested for Pregnancy before Chemoimmunotherapy: An Australian Cancer Centre Experience', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-154028
    Journal articles | 2021
    2021, 'Abnormal coagulation profiles in monoclonal gammopathy of undetermined significance: a case series', Pathology, 53, pp. 798 - 800, http://dx.doi.org/10.1016/j.pathol.2020.11.005
    Journal articles | 2021
    2021, 'COVID-19 vaccination in haematology patients: an Australian and New Zealand consensus position statement', Internal Medicine Journal, 51, pp. 763 - 768, http://dx.doi.org/10.1111/imj.15247
    Journal articles | 2021
    2021, 'Chromosome microarray characterisation of chromosome arm 12p loss associated with complex molecular karyotype and recurrent adverse cytogenetic markers in multiple myeloma', Genes Chromosomes and Cancer, 60, pp. 668 - 677, http://dx.doi.org/10.1002/gcc.22975
    Journal articles | 2021
    2021, 'Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac-modified CD19 CAR T cells', Blood, 138, pp. 1504 - 1509, http://dx.doi.org/10.1182/blood.2021010813
    Journal articles | 2021
    2021, 'Systematic Omission of Pregnant and Lactating Women from Malignant Haematology Trials Perpetuates a Cycle of Exclusion, Data Shortage and Disadvantage', BLOOD, 138, http://dx.doi.org/10.1182/blood-2021-149354
    Journal articles | 2021
    2021, 'Trends and Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Transplantation and Cellular Therapy, 27, pp. S399 - S401, http://dx.doi.org/10.1016/s2666-6367(21)00515-7
    Journal articles | 2021
    2021, 'Two cases of successful autologous stem cell transplantation in patients with multiple myeloma and concurrent chronic myeloid leukaemia', Bone Marrow Transplantation, 56, pp. 514 - 516, http://dx.doi.org/10.1038/s41409-020-01025-8
    Journal articles | 2021
    2021, 'Variation in Use of Immunoglobulin and Impact on Survival in Multiple Myeloma: A Report from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)', Blood, 138, pp. 4757 - 4757, http://dx.doi.org/10.1182/blood-2021-147622
    Journal articles | 2021
    2021, 'Weekly cyclophosphamide, subcutaneous bortezomib and dexamethathasone (CyBorD) for initial treatment of transplant-eligible patients with multiple myeloma: experience of two transplant centres', Bone Marrow Transplantation, 56, pp. 738 - 740, http://dx.doi.org/10.1038/s41409-020-01086-9
    Journal articles | 2020
    2020, 'Australian and New Zealand Registry of Anticoagulation in the Obese: Prescribing Patterns, Drug Levels and Patient Outcomes', Blood, 136, pp. 21 - 21, http://dx.doi.org/10.1182/blood-2020-143150
    Journal articles | 2020
    2020, 'Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID-19 pandemic', Internal Medicine Journal, 50, pp. 667 - 679, http://dx.doi.org/10.1111/imj.14859
    Journal articles | 2020
    2020, 'Trends in Outcomes in Australia and New Zealand in Autologous Stem Cell Transplantation in Older Patients with Multiple Myeloma: An Australasian Bone Marrow Transplant Recipient Registry Study', Blood, 136, pp. 11 - 12, http://dx.doi.org/10.1182/blood-2020-138991
    Journal articles | 2020
    2020, 'Weekly Cyclophosphamide, Subcutaneous Bortezomib and Dexamethathasone (CyBorD) for Initial Treatment of Transplant Eligible Patients with Multiple Myeloma: Experience of Two Transplant Centres', Blood, 136, pp. 42 - 43, http://dx.doi.org/10.1182/blood-2020-139269
    Journal articles | 2019
    2019, 'Massive Splenomegaly, An Unexpected Diagnosis', Pathology, 51, pp. S41 - S41, http://dx.doi.org/10.1016/j.pathol.2018.12.091
    Journal articles | 2018
    Favaloro EJ; McCaughan G; Mohammed S; Lau KK E; Gemmell R; Cavanaugh L; Donikian D; Kondo M; Brighton T; Pasalic L, 2018, 'HIT or miss? A comprehensive contemporary investigation of laboratory tests for heparin induced thrombocytopenia', Pathology, 50, pp. 426 - 436, http://dx.doi.org/10.1016/j.pathol.2017.11.089
    Journal articles | 2018
    2018, 'An unexpected diagnosis: leukaemic presentation of blastic plasmacytoid dendritic cell neoplasm with massive splenomegaly', Pathology, 50, pp. 773 - 775, http://dx.doi.org/10.1016/j.pathol.2018.05.007
    Journal articles | 2018
    2018, 'Anticoagulation at the extremes of body weight: choices and dosing', Expert Review of Hematology, 11, pp. 817 - 828, http://dx.doi.org/10.1080/17474086.2018.1517040
    Journal articles | 2018
    2018, 'Anticoagulation therapy in Australia', Annals of Blood, 3, pp. 48 - 48, http://dx.doi.org/10.21037/aob.2018.12.02
    Journal articles | 2017
    McCaughan G; Massey J; Sutton I; Curnow J, 2017, 'Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis', BMJ Case Reports, 2017, http://dx.doi.org/10.1136/bcr-2017-223016
    Journal articles | 2017
    2017, 'Clinical and laboratory diagnosis of heparin induced thrombocytopenia: an update', Pathology, 49, pp. 346 - 355, http://dx.doi.org/10.1016/j.pathol.2017.02.005
    Journal articles | 2016
    2016, 'Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma', Journal of Hematology and Oncology, 9, http://dx.doi.org/10.1186/s13045-016-0278-x
    Journal articles | 2013
    2013, 'Better estimates of survival for patients considering adjuvant chemotherapy after surgery for early non-small-cell lung cancer', Internal Medicine Journal, 43, pp. 424 - 429, http://dx.doi.org/10.1111/j.1445-5994.2012.02846.x
    Journal articles | 2013
    2013, 'Using scenarios to explain life expectancy in advanced cancer: Attitudes of people with a cancer experience', Supportive Care in Cancer, 21, pp. 369 - 376, http://dx.doi.org/10.1007/s00520-012-1526-4
    Journal articles | 2012
    2012, 'Using scenarios to explain survival time: Attitudes of people with a cancer experience.', Journal of Clinical Oncology, 30, pp. 9126 - 9126, http://dx.doi.org/10.1200/jco.2012.30.15_suppl.9126
  • Conference Abstracts | 2022
    2022, 'Role of Endomyocardial Biopsy and Mass Spectrometry for Precision in Cardiac Amyloid Subtyping: A Case Series', in Heart, Lung and Circulation, Elsevier BV, Vol. 31, pp. S99 - S100, http://dx.doi.org/10.1016/j.hlc.2022.06.123
    Conference Abstracts | 2021
    2021, 'A randomized, open-label, phase 3 study of low-dose selinexor and lenalidomide (Len) versus len maintenance post autologous stem cell transplant (ASCT) for newly diagnosed multiple myeloma (NDMM): ALLG MM23, Sealand.', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, Vol. 39, http://dx.doi.org/10.1200/JCO.2021.39.15_suppl.TPS8055
    Conference Papers | 2011
    2011, 'P5-15-02: Patients' Views about How Oncologists Should Explain Prognosis in Advanced Cancer.', in Cancer Research, American Association for Cancer Research (AACR), presented at Abstracts: Thirty-Fourth Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 6‐10, 2011; San Antonio, TX, http://dx.doi.org/10.1158/0008-5472.sabcs11-p5-15-02